+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA Hemodialysis Catheters Market Size, Share & Trends Analysis Report By Material (Polyurethane, and Silicone), By Product (Cuffed Tunneled, Non-Cuffed Tunneled, and Non-Tunneled), By Tip Configuration, By End User, By Country and Growth Forecast, 2023 - 2030

  • PDF Icon

    Report

  • January 2024
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5935697
The Latin America, Middle East and Africa Hemodialysis Catheters Market would witness market growth of 6.1% CAGR during the forecast period (2023-2030). In the year 2026, the LAMEA market's volume is expected to surge to 3,010.0 thousand units, showcasing a growth of 7.6% (2023-2030).

The primary application of these catheters lies in renal replacement therapy. These catheters are used to establish temporary vascular access for individuals with end-stage renal disease (ESRD) or acute kidney injury (AKI) who require regular hemodialysis. They provide a conduit for the efficient removal and return of blood during the dialysis process. In emergency medicine, these catheters are pivotal in rapidly establishing vascular access for urgent dialysis procedures.

Ongoing advancements in materials, design, and technology are shaping the landscape of these catheters. Manufacturers invest in research and development to introduce catheters with improved biocompatibility, reduced thrombogenicity, and innovative features such as antimicrobial coatings. These advancements aim to improve the safety and effectiveness of hemodialysis procedures. There is a noticeable trend towards the use of tunneled catheters. Unlike non-tunneled catheters, tunneled catheters are inserted with a portion of the catheter tunneled under the skin. This design reduces the risk of infections and provides more stable vascular access, making them preferable for long-term hemodialysis.

Diabetes and hypertension, two main risk factors for kidney disorders, including acute kidney injury (AKI), are highly prevalent in Saudi Arabia. The occurrence of infectious diseases in Saudi Arabia contributes to a higher incidence of AKI, particularly in cases of severe or untreated infections. The presence of chronic diseases beyond diabetes and hypertension, such as cardiovascular diseases and autoimmune conditions, contributes to the development of AKI in Saudi Arabia. Hence, due to these aspects, the market will expand across the LAMEA region in upcoming years.

The Brazil market dominated the LAMEA Hemodialysis Catheters Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $25.8 Million by 2030. The Argentina market is showcasing a CAGR of 6.7% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 5.8% during (2023 - 2030).

Based on Material, the market is segmented into Polyurethane, and Silicone. Based on Product, the market is segmented into Cuffed Tunneled, Non-Cuffed Tunneled, and Non-Tunneled. Based on Tip Configuration, the market is segmented into Step-Tip Catheters, Split-Tip Catheters, and Symmetric Catheters. Based on End User, the market is segmented into Hospitals, Clinics/Dialysis Centers, and Home Dialysis. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

  • Teleflex Incorporated
  • Medtronic Plc
  • AngioDynamics, Inc.
  • Bayer Ag
  • B.Braun Melsungen AG
  • Baxter International, Inc
  • NIPRO Corporation
  • Covalon Technologies Ltd.
  • Fresenius Medical Care AG & Co. KGaA
  • DaVita Inc.

Market Report Segmentation

By Material (Volume, Thousand Units, USD Billion, 2019-2030)
  • Polyurethane
  • Silicone
By Product (Volume, Thousand Units, USD Billion, 2019-2030)
  • Cuffed Tunneled
  • Non-Cuffed Tunneled
  • Non-Tunneled
By Tip Configuration (Volume, Thousand Units, USD Billion, 2019-2030)
  • Step-Tip Catheters
  • Split-Tip Catheters
  • Symmetric Catheters
By End User (Volume, Thousand Units, USD Billion, 2019-2030)
  • Hospitals
  • Clinics/Dialysis Centers
  • Home Dialysis
By Country (Volume, Thousand Units, USD Billion, 2019-2030)
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Hemodialysis Catheters Market, by Material
1.4.2 LAMEA Hemodialysis Catheters Market, by Product
1.4.3 LAMEA Hemodialysis Catheters Market, by Tip Configuration
1.4.4 LAMEA Hemodialysis Catheters Market, by End User
1.4.5 LAMEA Hemodialysis Catheters Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis
Chapter 4. LAMEA Hemodialysis Catheters Market by Material
4.1 LAMEA Polyurethane Market by Country
4.2 LAMEA Silicone Market by Country
Chapter 5. LAMEA Hemodialysis Catheters Market by Product
5.1 LAMEA Cuffed Tunneled Market by Country
5.2 LAMEA Non-Cuffed Tunneled Market by Country
5.3 LAMEA Non-Tunneled Market by Country
Chapter 6. LAMEA Hemodialysis Catheters Market by Tip Configuration
6.1 LAMEA Step-Tip Catheters Market by Country
6.2 LAMEA Split-Tip Catheters Market by Country
6.3 LAMEA Symmetric Catheters Market by Country
Chapter 7. LAMEA Hemodialysis Catheters Market by End User
7.1 LAMEA Hospitals Market by Country
7.2 LAMEA Clinics/Dialysis Centers Market by Country
7.3 LAMEA Home Dialysis Market by Country
Chapter 8. LAMEA Hemodialysis Catheters Market by Country
8.1 Brazil Hemodialysis Catheters Market
8.1.1 Brazil Hemodialysis Catheters Market by Material
8.1.2 Brazil Hemodialysis Catheters Market by Product
8.1.3 Brazil Hemodialysis Catheters Market by Tip Configuration
8.1.4 Brazil Hemodialysis Catheters Market by End User
8.2 Argentina Hemodialysis Catheters Market
8.2.1 Argentina Hemodialysis Catheters Market by Material
8.2.2 Argentina Hemodialysis Catheters Market by Product
8.2.3 Argentina Hemodialysis Catheters Market by Tip Configuration
8.2.4 Argentina Hemodialysis Catheters Market by End User
8.3 UAE Hemodialysis Catheters Market
8.3.1 UAE Hemodialysis Catheters Market by Material
8.3.2 UAE Hemodialysis Catheters Market by Product
8.3.3 UAE Hemodialysis Catheters Market by Tip Configuration
8.3.4 UAE Hemodialysis Catheters Market by End User
8.4 Saudi Arabia Hemodialysis Catheters Market
8.4.1 Saudi Arabia Hemodialysis Catheters Market by Material
8.4.2 Saudi Arabia Hemodialysis Catheters Market by Product
8.4.3 Saudi Arabia Hemodialysis Catheters Market by Tip Configuration
8.4.4 Saudi Arabia Hemodialysis Catheters Market by End User
8.5 South Africa Hemodialysis Catheters Market
8.5.1 South Africa Hemodialysis Catheters Market by Material
8.5.2 South Africa Hemodialysis Catheters Market by Product
8.5.3 South Africa Hemodialysis Catheters Market by Tip Configuration
8.5.4 South Africa Hemodialysis Catheters Market by End User
8.6 Nigeria Hemodialysis Catheters Market
8.6.1 Nigeria Hemodialysis Catheters Market by Material
8.6.2 Nigeria Hemodialysis Catheters Market by Product
8.6.3 Nigeria Hemodialysis Catheters Market by Tip Configuration
8.6.4 Nigeria Hemodialysis Catheters Market by End User
8.7 Rest of LAMEA Hemodialysis Catheters Market
8.7.1 Rest of LAMEA Hemodialysis Catheters Market by Material
8.7.2 Rest of LAMEA Hemodialysis Catheters Market by Product
8.7.3 Rest of LAMEA Hemodialysis Catheters Market by Tip Configuration
8.7.4 Rest of LAMEA Hemodialysis Catheters Market by End User
Chapter 9. Company Profiles
9.1 Teleflex Incorporated
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental Analysis
9.1.4 Research & Development Expense
9.1.5 SWOT Analysis
9.2 Medtronic PLC
9.2.1 Company overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 SWOT Analysis
9.3 Baxter International, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental Analysis
9.3.4 Research & Development Expense
9.3.5 SWOT Analysis
9.4 AngioDynamics, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 SWOT Analysis
9.5 B. Braun Melsungen AG
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 SWOT Analysis
9.6 Nipro Corporation
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expenses
9.7 Fresenius Medical Care AG & Co. KGaA
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 SWOT Analysis
9.8 Covalon Technologies Ltd.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Research & Development Expenses
9.9 DaVita Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 SWOT Analysis
9.10. Bayer AG
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expense
9.10.5 SWOT Analysis

Companies Mentioned

  • Teleflex Incorporated
  • Medtronic Plc
  • AngioDynamics, Inc.
  • Bayer Ag
  • B. Braun Melsungen AG
  • Baxter International, Inc
  • NIPRO Corporation
  • Covalon Technologies Ltd.
  • Fresenius Medical Care AG & Co. KGaA
  • DaVita Inc.

Methodology

Loading
LOADING...